Vita Therapeutics Funding: $35M Raised, Series A (2024)

Vita Therapeutics is based in Baltimore, Country. It has raised $35M in total funding. Latest round: Series A.

Vita Therapeutics funding overview

Vita Therapeutics is based in Baltimore, Country. Vita Therapeutics has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Vita Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Early Light Ventures, Kiwi Bio, SEM Life Science. 3 distinct backers are named across the disclosed rounds.

Vita Therapeutics at a glance

Total raised
$35M
Latest round
Series A
Latest round date
January 2024
Headquarters
Baltimore, Country
Notable investors
Early Light Ventures, Kiwi Bio, SEM Life Science

Frequently asked about Vita Therapeutics funding

How much has Vita Therapeutics raised?
Vita Therapeutics has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Vita Therapeutics?
Early Light Ventures, Kiwi Bio, SEM Life Science are named among the investors backing Vita Therapeutics.
What was the latest Vita Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Vita Therapeutics based?
Vita Therapeutics is based in Baltimore, Country.
When did Vita Therapeutics last raise?
The last disclosed Vita Therapeutics round closed in January 2024 at Series A.

Round data for Vita Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Baltimore and backer lists below.

Companies related to Vita Therapeutics (19)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026